Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Author:
Publisher
Elsevier BV
Reference27 articles.
1. Cluster analysis and clinical asthma phenotypes;Haldar;Am J Respir Crit Care Med,2008
2. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics;Flood-Page;J Clin Invest,2003
3. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma;Flood-Page;Am J Respir Crit Care Med,2007
4. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway;Flood-Page;Am J Respir Crit Care Med,2003
5. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response;Leckie;Lancet,2000
Cited by 1995 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Real-world respiratory effectiveness of mepolizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis;Respiratory Medicine;2025-09
2. The era of multiple biologics: Is combination and switching an option in the management of severe asthma?;Pulmonary Pharmacology & Therapeutics;2025-09
3. Comparative Effectiveness of Dupilumab Versus Mepolizumab and Benralizumab in Asthma: A Multinational Retrospective Cohort Study;The Journal of Allergy and Clinical Immunology: In Practice;2025-07
4. Response to IL-5/IL-5R Antagonists and Remission Rate in Patients With Severe Asthma Who Would Have Been Excluded From the Pivotal Clinical Trials;The Journal of Allergy and Clinical Immunology: In Practice;2025-07
5. Frequent exacerbator—a novel endotype of pediatric asthma;Journal of Allergy and Clinical Immunology;2025-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2025 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3